$75.6 Million is the total value of ISZO CAPITAL MANAGEMENT LP's 4 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NTP | Buy | NAM TAI PPTY INC | $34,364,000 | -7.7% | 3,818,170 | +0.0% | 45.47% | -21.8% |
| CDMO | Sell | AVID BIOSERVICES INC | $24,034,000 | -10.2% | 4,534,694 | -5.1% | 31.80% | -24.0% |
| XPEL | New | XPEL INC | $16,796,000 | – | 1,423,393 | +100.0% | 22.23% | – |
| TOCA | New | TOCAGEN INC | $375,000 | – | 565,925 | +100.0% | 0.50% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NAM TAI PPTY INC | 16 | Q3 2022 | 60.5% |
| AVID BIOSERVICES INC | 13 | Q4 2021 | 46.6% |
| XPEL INC | 10 | Q4 2021 | 22.3% |
| TARO PHARMACEUTICALS INDUS LTD | 8 | Q4 2015 | 85.7% |
| AMERCO | 8 | Q4 2015 | 11.2% |
| NATHANS FAMOUS INC NEW | 7 | Q1 2017 | 68.9% |
| MMA CAP MGMT LLC | 7 | Q1 2017 | 17.8% |
| CBL & ASSOC PPTYS INC | 6 | Q3 2023 | 95.2% |
| LIFECORE BIOMEDICAL INC | 6 | Q4 2022 | 35.1% |
| CRYO-CELL INTL INC | 6 | Q4 2022 | 11.0% |
View ISZO CAPITAL MANAGEMENT LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View ISZO CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.